Evidence map›Paper›PMID 42417098›Full record

ArticlePrenatal diagnosis2026

Novel and High-Throughput Method of Isolating Single Fetal Cells Using FACS for NIPT.

Ripudaman Singh, Bolette Hestbek Nicolaisen, Mathias Kølvraa, Inga Baasch Christensen, Mads Tang Dalsgaard, Lars Henning Pedersen, Niels Uldbjerg, Ida Vogel, Lotte Hatt, Katarina Ravn

Abstract read
In one paragraph

Article in Prenatal diagnosis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ripudaman SinghARCEDI Biotech, Vejle, Denmark.ORCID https://orcid.org/0000-0003-2657-0661
Bolette Hestbek NicolaisenARCEDI Biotech, Vejle, Denmark.ORCID https://orcid.org/0000-0002-8254-3134
Mathias KølvraaARCEDI Biotech, Vejle, Denmark.ORCID https://orcid.org/0000-0002-7177-7234
Inga Baasch ChristensenARCEDI Biotech, Vejle, Denmark.
Mads Tang DalsgaardARCEDI Biotech, Vejle, Denmark.
Lars Henning PedersenDepartment of Obstetrics and Gynaecology, Aarhus University Hospital, Aarhus, Denmark.ORCID https://orcid.org/0000-0001-6726-1991
Niels UldbjergDepartment of Obstetrics and Gynaecology, Aarhus University Hospital, Aarhus, Denmark.ORCID https://orcid.org/0000-0002-6449-6426
Ida VogelDepartment of Obstetrics and Gynaecology, Aarhus University Hospital, Aarhus, Denmark.ORCID https://orcid.org/0000-0002-1125-0393
Lotte HattARCEDI Biotech, Vejle, Denmark.ORCID https://orcid.org/0000-0003-0141-9172
Katarina RavnARCEDI Biotech, Vejle, Denmark.ORCID https://orcid.org/0000-0001-5428-8781

Funding

ARCEDI Biotech
6 · The paper itself

Abstract

objectiveTo evaluate fluorescence activated cell sorting (FACS) as a method of single-cell isolation of rare circulating fetal cells from maternal blood for use in cell-based non-invasive prenatal testing (cbNIPT).

methodBlood samples (30 mL) were collected from 75 'low-risk' pregnant women (gestational age 10-15 weeks). Fetal cells were enriched and stained using magnetic activated cell sorting. Following enrichment, single fetal cells were sorted in individual PCR tubes by FACS. After cell lysis, verification of fetal cell origin was performed using short tandem repeat (STR) analysis with the GlobalFiler PCR Amplification kit.

resultsAn average of 13.7 cells were sorted using FACS. STR analysis identified 8.2 fetal cells on average, representing 60.2% of the sorted cells. The four-step single-cell isolation procedure facilitated an overall enrichment of approximately 16-million-fold. One sample did not render any fetal cell, corresponding to 1.3% of the samples.

conclusionFACS, which is typically used for segregation of large populations of cells, can be used for single-cell isolation of rare fetal cells in an automated setup. This not only helps in making cell isolation faster and high throughput but also provides fetal cells for a more comprehensive genetic analysis of the fetus.

Indexed as

FetusFlow CytometryMaternal Serum Screening TestsNoninvasive Prenatal TestingSingle-Cell AnalysisCell SeparationFemaleHumansMicrosatellite RepeatsPregnancyaneuploidiescopy number variantsfetal cells in maternal bloodfluorescence activated cell sortingnoninvasive prenatal testingprenatal diagnosis

Identifiers

PMID42417098
PMCPMC13571807

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.